Clinical value of combined detection of serum total sialic acid, sialidase and high sensitivity C-reactive protein in patients with acute myocardial infarction

Fang-yuan ZHOU,Yan LI,Wen DAI

DOI: https://doi.org/10.3969/j.issn.1003-6350.2016.15.006

2016-01-01

Abstract:Objective To evaluate the clinical value of combined detection of serum total sialic acid (TSA), neuramidinase (NEU) and high sensitivity C-reactive protein (hs-CRP) in the diagnosis and prognosis evaluation of acute myocardial infarction (AMI). Methods Ninety-nine healthy subjects (control group) and 210 AMI patients (case group) who visited the Renmin Hospital of Wuhan University from August to December 2015 were selected as the study subjects. According to AMI type, the case group was divided into ST segment elevation type AMI group (STEMI group) and non ST segment elevation type AMI group (NSTEMI group). According to AMI site, the patients were divided into anterior wall infarction group and inferior wall infarction group. According to whether the hospital death occurred, the case group was divided into the hospital death group and survival group. The levels of serum TSA, NEU and hs-CRP were detected and then compared between groups. Results Compared with the control group, the levels of TSA, NEU, and hs-CRP in case group were significantly increased [717 (612~834) mg/L vs 568 (534~605) mg/L, U=2 346.5, P<0.01;16.69 ng/mL vs 13.32 ng/mL, U=5 465.0, P<0.01;14.34 mg/dL vs 0.35 mg/dL, U=458.0, P<0.01]. There was no sta-tistically significant difference in the levels of TSA, NEU, and hs-CRP between STEMI group and NSTEMI group. Com-pared with the inferior wall infarction group, the serum TSA level and hs-CRP level in the anterior wall infarction group were significantly increased (746 mg/L vs 648 mg/L, U=2 302.5, P<0.01;19.63 mg/dL vs 7.80 mg/dL, U=2 169.5, P<0.01). Compared with the survival group, the level of serum TSA and hs-CRP in the hospital death group were significantly in-creased (948 mg/L vs 697 mg/L, U=1 006.5, P<0.01;58.37 mg/mL vs 11.00 mg/mL, U=1 052.0, P<0.01). Spearman cor-relation analysis showed that serum TSA and hs-CRP levels were significantly positively correlated (r=0.623, P<0.01) in AMI patients. After drawing the receiver operating characteristic curve, the area under the curve was 86.0% (P<0.01) when the serum TSA was used for the diagnosis of AMI, and the area under the curve was 97.3%(P<0.01) when the se-rum hs-CRP was used for the diagnosis of AMI. The area under the curve was 97.4%(P<0.01) when combined serum TSA and hs-CRP was used in the diagnosis of AMI. Conclusion The combined detection of serum TSA, NEU and hs-CRP has a certain clinical value for the diagnosis and prognosis evaluation of AMI.